Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilde S Ørbo

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Rheumatology and Therapy|March 27, 2026
Characterizing Adherence to a Mobile Health App for Patient-Reported Outcomes in Rheumatoid ArthritisZeynep Serra Tuzun, Leah Santacroce, Hilde S Ørbo, et al.
The Lancet. Rheumatology|April 25, 2026
Effectiveness and persistence of biological and targeted synthetic treatment in patients with rheumatoid arthritis and chronic kidney disease: a multicentre, prospective cohort studySho Fukui, Hilde S Ørbo, Sara K Tedeschi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 3, 2025
Longitudinal Changes in Serum Urate Levels from Pre-menopause through Post-menopause: Interrupted Time-Series AnalysesShreya Billa, Sho Fukui, Misti L Paudel, et al.
RMD Open|April 10, 2024
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort studyHilde S Ørbo, Kristin H Bjørlykke, Joseph Sexton, et al.
The Lancet. Rheumatology|November 23, 2022
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort studyKristin H Bjørlykke, Hilde S Ørbo, Anne T Tveter, et al.
The Lancet Regional Health. Europe|December 3, 2024
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort studyHilde S Ørbo, Taissa de Matos Kasahara, Asia-Sophia Wolf, et al.
Ebiomedicine|September 11, 2024
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort studyAsia-Sophia Wolf, Kristin H Bjørlykke, Hilde S Ørbo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Rheumatology and Therapy|March 27, 2026
Characterizing Adherence to a Mobile Health App for Patient-Reported Outcomes in Rheumatoid ArthritisZeynep Serra Tuzun, Leah Santacroce, Hilde S Ørbo, et al.
The Lancet. Rheumatology|April 25, 2026
Effectiveness and persistence of biological and targeted synthetic treatment in patients with rheumatoid arthritis and chronic kidney disease: a multicentre, prospective cohort studySho Fukui, Hilde S Ørbo, Sara K Tedeschi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 3, 2025
Longitudinal Changes in Serum Urate Levels from Pre-menopause through Post-menopause: Interrupted Time-Series AnalysesShreya Billa, Sho Fukui, Misti L Paudel, et al.
RMD Open|April 10, 2024
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort studyHilde S Ørbo, Kristin H Bjørlykke, Joseph Sexton, et al.
The Lancet. Rheumatology|November 23, 2022
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort studyKristin H Bjørlykke, Hilde S Ørbo, Anne T Tveter, et al.
The Lancet Regional Health. Europe|December 3, 2024
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort studyHilde S Ørbo, Taissa de Matos Kasahara, Asia-Sophia Wolf, et al.
Ebiomedicine|September 11, 2024
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort studyAsia-Sophia Wolf, Kristin H Bjørlykke, Hilde S Ørbo, et al.
Pageof 1